These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration. Iwamoto I; Tomoe S; Tomioka H; Yoshida S J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil aggregating properties of PAF-acether and leukotriene B4. Ford-Hutchinson AW Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012 [TBL] [Abstract][Full Text] [Related]
7. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Karmeli F; Eliakim R; Okon E; Rachmilewitz D Gastroenterology; 1991 May; 100(5 Pt 1):1206-16. PubMed ID: 1707383 [TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4-induced neutrophil-mediated endothelial leakage in vitro and in vivo. Rosengren S; Olofsson AM; von Andrian UH; Lundgren-Akerlund E; Arfors KE J Appl Physiol (1985); 1991 Oct; 71(4):1322-30. PubMed ID: 1661722 [TBL] [Abstract][Full Text] [Related]
9. Role of leukotriene B4 in substance P-induced granulocyte infiltration in mouse skin. Iwamoto I; Tomoe S; Yoshida S Regul Pept; 1993 Jul; 46(1-2):225-7. PubMed ID: 7692497 [No Abstract] [Full Text] [Related]
10. Inhibitory effect of the Ruscus extract and of the flavonoid hesperidine methylchalcone on increased microvascular permeability induced by various agents in the hamster cheek pouch. Bouskela E; Cyrino FZ; Marcelon G J Cardiovasc Pharmacol; 1993 Aug; 22(2):225-30. PubMed ID: 7692162 [TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4: an inflammatory mediator in vivo. Bray MA; Ford-Hutchinson AW; Smith MJ Prostaglandins; 1981 Aug; 22(2):213-22. PubMed ID: 6270742 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Brain SD; Williams TJ Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378 [TBL] [Abstract][Full Text] [Related]
13. Phospholipase D activation by platelet-activating factor, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils. Phospholipase D activation is involved in enzyme release. Kanaho Y; Kanoh H; Saitoh K; Nozawa Y J Immunol; 1991 May; 146(10):3536-41. PubMed ID: 1851192 [TBL] [Abstract][Full Text] [Related]
14. Leukotrienes do not modify the effects of PAF on human platelet aggregation. Filep J; Földes-Filep E Thromb Res; 1987 Mar; 45(6):865-70. PubMed ID: 3035743 [No Abstract] [Full Text] [Related]
16. Leukotrienes B4 and C4 have distinct microcirculatory actions in vivo. Björk J; Dahlén SE; Hedqvist P; Arfors KE Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():1-6. PubMed ID: 6303078 [TBL] [Abstract][Full Text] [Related]
17. Oxygen free radicals and leukotriene B4 induced increase in vascular leakage is mediated by polymorphonuclear leukocytes. Björk J; Arfors KE Agents Actions Suppl; 1982; 11():63-72. PubMed ID: 6295114 [TBL] [Abstract][Full Text] [Related]
18. Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn. Tan ND; Davidson D Pediatr Res; 1995 Jul; 38(1):11-6. PubMed ID: 7478787 [TBL] [Abstract][Full Text] [Related]
19. Roles of arachidonate metabolites in thrombus formation and leukocyte migration: analyses at microcirculatory level. Katori M; Sasaki K; Nagai K; Hirose R Jpn Circ J; 1987 Apr; 51(4):445-50. PubMed ID: 3039189 [TBL] [Abstract][Full Text] [Related]